Olfactory Neuroanatomy: Brain Dissection Lab

When neurological deficits such as facial drooping are observed, cranial nerve examination becomes indicated. The examination systematically assesses multiple cranial nerves: facial nerve motor function through jaw resistance testing, reflex testing via patellar reflex, visual acuity using Snellen chart, ophthalmoscopic examination for optic nerve health, hearing assessment through otoscopic examination and whispered voice tests, hypoglossal nerve function through tongue mobility assessment, olfactory function using scent identification tests, and somatic sensation using sharp-dull discrimination. Integration of these findings guides diagnosis, identifying specific nerve involvement such as accessory nerve damage.

Olfactory testing evaluates the sense of smell by presenting different scents (such as cinnamon, paprika, nutmeg, and turmeric) and asking the subject to identify them with eyes closed. This assesses the olfactory nerve (CN I) function and the brain's ability to process olfactory information.

Olfactory function assessment tests the sense of smell through a baseline identification test and a fruit identification test. The baseline test uses a familiar substance like perfume to confirm functional smell. The fruit identification test presents four fruits (lemon, orange, peach, lime) and asks the patient to identify each by smell. The patient takes deep breaths and identifies each fruit. The examiner notes correct and incorrect identifications, with difficult fruits like lime receiving partial credit. This assesses olfactory nerve function and ability to distinguish different scents.

The cranial nerve examination systematically assesses each pair: Olfactory (I) - test smell with eyes closed using common objects. Optic (II) - test visual acuity at near and distance, pupil reactions with light, fundus with ophthalmoscope, and visual fields by bringing fingers from quadrants. Oculomotor, Trochlear, and Abducens (III, IV, VI) - test eye movements for lateral gaze (VI controls lateral rectus), upward gaze (IV controls superior oblique), and accommodation. Trigeminal (V) - test sensation over ophthalmic, maxillary, and mandibular divisions, motor function by jaw clenching and jaw jerk reflex, and corneal reflex. Facial (VII) - test facial muscle strength by eye closure against resistance and cheek inflation. Vestibulocochlear (VIII) - test hearing by whispering and distinguish conductive from sensorineural deafness with Rinne's test. Glossopharyngeal and Vagus (IX, X) - observe uvula position and test gag reflex. Accessory (XI) - test sternomastoid and trapezius strength by shoulder shrugging and jaw pushing. Hypoglossal (XII) - test tongue protrusion, noting unilateral deviation indicates lesion.

A cranial nerve examination systematically assesses the function of all 12 cranial nerves through specific tests: visual acuity and field testing (CN II), facial sensation and muscle movement (CN V, VII), olfactory function (CN I), taste and oral examination (CN VII, IX), auditory function including whisper tests and tuning fork assessments (CN VIII), and reflex testing (CN III, VII, XII). This comprehensive neurological assessment evaluates sensory, motor, and reflex functions across different cranial nerve pairs.

Neurodegenerative diseases including Alzheimer's and Parkinson's involve progressive neuronal degeneration leading to disability and death. Both diseases share a common feature: olfactory dysfunction appears 10-15 years before typical clinical symptoms. Parkinson's involves dopamine neuron degeneration in the substantia nigra due to alpha-synuclein aggregation, causing motor symptoms. Alzheimer's involves amyloid-beta plaques and tau tangles causing temporal cortex degeneration, leading to memory loss. The olfactory system detects environmental volatiles through receptors in the olfactory epithium, sending signals to the olfactory bulb. Two main dysfunction types exist: quantitative (hyposmia/anosmia) and qualitative (parosmia/phantosmia). Factors influencing olfactory function include age, sex, education, smoking, and alcohol consumption. Meta-analysis reveals that both Alzheimer's and Parkinson's cause significant olfactory impairment across multiple tasks, but with distinct patterns: Parkinson's affects all tasks uniformly while Alzheimer's shows particular impairment in memory-dependent tasks like identification and recognition. This distinction may help differentiate between conditions.

This major section establishes olfactory dysfunction as a powerful early biomarker for multiple neurodegenerative diseases. Parkinson's disease causes smell loss in nearly all patients, even before motor symptoms appear, making it more prevalent than some cardinal signs like tremor. Alzheimer's disease similarly produces early olfactory impairment that precedes cognitive decline. The UPSIT aids prediction of future cognitive decline, sometimes outperforming traditional measures like age and hippocampal volume. Multiple sclerosis and epilepsy also produce characteristic olfactory deficits. Genetic research shows that relatives of Parkinson's patients with poorest smell scores develop the disease while those with normal scores do not. The dual hit hypothesis proposes that environmental toxins enter through the olfactory system and induce pathology that eventually manifests as motor symptoms. Nicotine appears to offer protective effects, as current smokers with Parkinson's outperform past smokers and never-smokers on olfactory tests.

Olfactory dysfunction is a common early indicator of neurodegenerative diseases such as Parkinson's and Alzheimer's, often appearing years before motor or cognitive symptoms manifest; this makes olfactory testing a valuable tool for early diagnosis, differential diagnosis, and prognosis prediction in these conditions, with approximately 85% of Alzheimer's and Parkinson's patients showing olfactory impairment in early stages.

Olfactory dysfunction in neurodegenerative diseases results from pathological protein accumulation in olfactory pathways. In Parkinson's disease, abnormal proteins accumulate in olfactory regions, damaging olfactory neurons. In Alzheimer's disease, beta-amyloid and tau proteins accumulate in olfactory pathways, disrupting neural connections. These changes occur years before motor symptoms appear, making olfactory dysfunction an important early diagnostic marker.

Anosmia is complete loss of smell, either temporary (from nasal congestion in colds/sinusitis blocking receptors) or permanent (from damage in Parkinson's/Alzheimer's). Hyposmia is reduced ability to detect odors, which can be temporary or permanent. Hyperosmia is increased sensitivity where even small odor amounts are perceived strongly, occurring in brain injury, epilepsy, and neurotic conditions. These disorders demonstrate how olfactory function depends on both peripheral receptor integrity and central nervous system processing.

For large olfactory groove meningiomas in elderly patients with comorbidities, a bifrontal craniotomy approach is preferred over endoscopic endonasal surgery due to better vascular control of the anterior cerebral artery branches; the surgical technique involves ligating the proximal sphenoid sinus at the crista galli, performing circumferential tumor dissection while preserving olfactory function when possible, and reconstructing the cranial base with a pedicled flap to prevent CSF leak and infection.

Olfactory groove meningiomas arise from the anterior cranial fossa along the cribriform plate and planum sphenoidale, presenting with anosmia, frontal lobe symptoms, and visual disturbances; surgical management requires understanding the critical anatomical relationships including the cribriform plate, olfactory bulbs, optic apparatus, and anterior cerebral arteries, with the bifrontal approach being a key surgical option that provides excellent exposure of the optic apparatus and allows control of ethmoidal feeders through orbital osteotomy while requiring careful preservation of the recurrent artery of Heubner and consideration of patient positioning with slight extension to utilize gravity-based retraction.

The history of olfactory groove meningioma surgery reflects evolving surgical philosophies: Cushing advocated unilateral frontal craniectomy with brain wedging, while Dandy championed bilateral approaches. European centers developed midline approaches avoiding frontal sinus sacrifice. Modern approaches combine pterional and subfrontal corridors for optimal access. Image-guided navigation helps precisely locate midline osteotomy while avoiding sinus injury. Drilling the orbital roof laterally improves viewing angles into the anterior cranial fossa. Leaving a 3mm bone bridge above the frontal sinus prevents cerebrospinal fluid leaks. Early vascular control through the frontal corridor creates a dry field for piecemeal tumor removal. Modern outcomes demonstrate gross total resection rates of 60-100% with clinical improvement in 62-100% of patients, and overall mortality decreasing to approximately 1%.

Anterior cranial fossa meningioma surgery requires thorough understanding of anatomy including the frontal sinus and triple junction. The vascular supply to the base must be addressed early. A systematic approach involves: (1) approaching the base and de-vascularizing the tumor, (2) debulking the tumor, (3) proceeding to the periphery, and (4) exercising the tumor. Large bipolar coagulators should be used rather than micro-bipolars, with settings at 40-45 degrees. The arachnoid plane is the most important structure, and surgeons should stay outside it and lift it to separate it from the tumor. Surgical approach selection depends on tumor location: for tuberculum sellae meningiomas, the opposite side approach provides better visualization underneath the optic nerve. For olfactory groove meningiomas, a unilateral approach is preferred. Complications include visual deterioration (4% of cases) and CSF rhinorrhea (3% of cases), with rates significantly lower with transcranial approaches compared to endoscopic approaches.

Working through anterior ethmoid air cells lateral to the cribriform plate provides access to the anterior cranial fossa floor, formed by the lamina papyracea creating the medial orbital wall. Angle drills can open the frontal sinus floor and extend access to the sphenoid. The optic canal and vidian nerve traverse the cavernous sinus. Removing ethmoid labyrinth exposes the anterior and posterior ethmoidal arteries, cribriform plate, and ethmoid labyrinth extending to the frontal bone, enabling access to C1-C2 vertebrae. The olfactory mucosa must be preserved; anterior ethmoidal arteries should be sacrificed medial to it to prevent orbital hematoma if divided laterally. An osteotomy around the cribriform plate can preserve olfactory mucosa while creating exposure.